Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial

BACKGROUND. Genital herpes simplex virus type 2 (HSV-2) infection causes recurrent lesions and frequent viral shedding. GEN-003 is a candidate therapeutic vaccine containing HSV-2 gD2∆TMR and ICP4.2, and Matrix-M2 adjuvant. METHODS. Persons with genital herpes were randomized into 3 dose cohorts to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Bernstein, David I., Wald, Anna, Warren, Terri, Fife, Kenneth, Tyring, Stephen, Lee, Patricia, Van Wagoner, Nick, Magaret, Amalia, Flechtner, Jessica B., Tasker, Sybil, Chan, Jason, Morris, Amy, Hetherington, Seth
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Major Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206854/
https://ncbi.nlm.nih.gov/pubmed/28329211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares